HEADER HYDROLASE 30-JAN-06 2FV9 TITLE CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH JMV 390-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADAM 17; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17, TNF-ALPHA- COMPND 5 CONVERTING ENZYME, TNF-ALPHA CONVERTASE, SNAKE VENOM-LIKE PROTEASE, COMPND 6 CD156B ANTIGEN; COMPND 7 EC: 3.4.24.86; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADAM17, CSVP, TACE; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS TACE ADAM33 ZN-ENDOPEPTIDASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR P.ORTH REVDAT 7 30-AUG-23 2FV9 1 REMARK REVDAT 6 20-OCT-21 2FV9 1 REMARK SEQADV LINK REVDAT 5 18-OCT-17 2FV9 1 REMARK REVDAT 4 01-FEB-17 2FV9 1 TITLE REVDAT 3 13-JUL-11 2FV9 1 VERSN REVDAT 2 24-FEB-09 2FV9 1 VERSN REVDAT 1 14-MAR-06 2FV9 0 JRNL AUTH R.N.INGRAM,P.ORTH,C.L.STRICKLAND,H.V.LE,V.MADISON,B.M.BEYER JRNL TITL STABILIZATION OF THE AUTOPROTEOLYSIS OF TNF-ALPHA CONVERTING JRNL TITL 2 ENZYME (TACE) RESULTS IN A NOVEL CRYSTAL FORM SUITABLE FOR JRNL TITL 3 STRUCTURE-BASED DRUG DESIGN STUDIES. JRNL REF PROTEIN ENG.DES.SEL. V. 19 155 2006 JRNL REFN ISSN 1741-0126 JRNL PMID 16459338 JRNL DOI 10.1093/PROTEIN/GZJ014 REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 34962 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.300 REMARK 3 FREE R VALUE TEST SET COUNT : 516 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3979 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 103 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.80400 REMARK 3 B22 (A**2) : 2.13700 REMARK 3 B33 (A**2) : 3.66700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : MSI_CNX_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : MSI_CNX_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 3 : MSI_CNX_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : PARA.PRO REMARK 3 PARAMETER FILE 5 : IMU_CIT_PAR.PRO REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FV9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036353. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRROR GREEN REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35008 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY: 1BKC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 6K, 10% 2-PROPANOL, 100 MM REMARK 280 SODIUM CITRATE, PH 5.6, VAPOR DIFFUSION, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.89950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.04600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.11050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.04600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.89950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.11050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 357 REMARK 465 ALA A 358 REMARK 465 ASN A 359 REMARK 465 SER A 360 REMARK 465 PRO B 218 REMARK 465 ASP B 219 REMARK 465 SER B 474 REMARK 465 ASN B 475 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 241 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 302 CG CD CE NZ REMARK 470 SER A 355 OG REMARK 470 SER A 441 CB OG REMARK 470 ARG B 241 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 286 CG CD CE NZ REMARK 470 GLU B 295 CG CD OE1 OE2 REMARK 470 LYS B 302 CG CD CE NZ REMARK 470 GLU B 307 CG CD OE1 OE2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 LYS B 309 CG CD CE NZ REMARK 470 ARG B 357 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE A 343 O HOH A 477 2.15 REMARK 500 O ALA A 301 O HOH A 515 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 313 N - CA - C ANGL. DEV. = -16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 241 17.40 59.72 REMARK 500 ASN A 269 11.68 53.00 REMARK 500 ALA A 270 -114.59 -120.70 REMARK 500 SER A 355 -167.38 -117.04 REMARK 500 CYS A 365 118.82 71.92 REMARK 500 ALA A 424 67.98 -150.51 REMARK 500 TRP B 267 -9.06 -59.71 REMARK 500 ASN B 269 10.66 54.27 REMARK 500 ALA B 270 -109.24 -118.06 REMARK 500 CYS B 365 116.16 73.04 REMARK 500 ALA B 424 67.04 -151.77 REMARK 500 ALA B 439 29.76 46.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 1 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 INN A 9 O REMARK 620 2 INN A 9 O4 81.5 REMARK 620 3 HIS A 405 NE2 98.2 91.5 REMARK 620 4 HIS A 409 NE2 165.6 93.3 95.3 REMARK 620 5 HIS A 415 NE2 87.7 163.6 102.3 94.2 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 4 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 002 B 2 O2 REMARK 620 2 002 B 2 O3 77.8 REMARK 620 3 HIS B 405 NE2 95.9 94.4 REMARK 620 4 HIS B 409 NE2 95.9 170.8 92.9 REMARK 620 5 HIS B 415 NE2 158.0 91.5 104.2 92.1 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: N-{(2R)-2-[2-(HYDROXYAMINO)-2-OXOETHYL]-4- REMARK 630 METHYLPENTANOYL}-3-METHYL-L-VALYL-N-(2-AMINOETHYL)-L-ALANINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 INN A 9 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 2HM TBG ALA EDN REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE INN A 9 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 002 B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BKC RELATED DB: PDB REMARK 900 RELATED ID: 2DDF RELATED DB: PDB REMARK 900 RELATED ID: 2FV5 RELATED DB: PDB DBREF 2FV9 A 218 475 UNP P78536 ADA17_HUMAN 218 475 DBREF 2FV9 B 218 475 UNP P78536 ADA17_HUMAN 218 475 SEQADV 2FV9 ALA A 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 2FV9 GLY A 353 UNP P78536 VAL 353 ENGINEERED MUTATION SEQADV 2FV9 GLN A 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQADV 2FV9 ALA B 266 UNP P78536 SER 266 ENGINEERED MUTATION SEQADV 2FV9 GLY B 353 UNP P78536 VAL 353 ENGINEERED MUTATION SEQADV 2FV9 GLN B 452 UNP P78536 ASN 452 ENGINEERED MUTATION SEQRES 1 A 258 PRO ASP PRO MET LYS ASN THR CYS LYS LEU LEU VAL VAL SEQRES 2 A 258 ALA ASP HIS ARG PHE TYR ARG TYR MET GLY ARG GLY GLU SEQRES 3 A 258 GLU SER THR THR THR ASN TYR LEU ILE GLU LEU ILE ASP SEQRES 4 A 258 ARG VAL ASP ASP ILE TYR ARG ASN THR ALA TRP ASP ASN SEQRES 5 A 258 ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE GLU GLN ILE SEQRES 6 A 258 ARG ILE LEU LYS SER PRO GLN GLU VAL LYS PRO GLY GLU SEQRES 7 A 258 LYS HIS TYR ASN MET ALA LYS SER TYR PRO ASN GLU GLU SEQRES 8 A 258 LYS ASP ALA TRP ASP VAL LYS MET LEU LEU GLU GLN PHE SEQRES 9 A 258 SER PHE ASP ILE ALA GLU GLU ALA SER LYS VAL CYS LEU SEQRES 10 A 258 ALA HIS LEU PHE THR TYR GLN ASP PHE ASP MET GLY THR SEQRES 11 A 258 LEU GLY LEU ALA TYR GLY GLY SER PRO ARG ALA ASN SER SEQRES 12 A 258 HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SER PRO VAL SEQRES 13 A 258 GLY LYS LYS ASN ILE TYR LEU ASN SER GLY LEU THR SER SEQRES 14 A 258 THR LYS ASN TYR GLY LYS THR ILE LEU THR LYS GLU ALA SEQRES 15 A 258 ASP LEU VAL THR THR HIS GLU LEU GLY HIS ASN PHE GLY SEQRES 16 A 258 ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU CYS ALA PRO SEQRES 17 A 258 ASN GLU ASP GLN GLY GLY LYS TYR VAL MET TYR PRO ILE SEQRES 18 A 258 ALA VAL SER GLY ASP HIS GLU ASN ASN LYS MET PHE SER SEQRES 19 A 258 GLN CYS SER LYS GLN SER ILE TYR LYS THR ILE GLU SER SEQRES 20 A 258 LYS ALA GLN GLU CYS PHE GLN GLU ARG SER ASN SEQRES 1 B 258 PRO ASP PRO MET LYS ASN THR CYS LYS LEU LEU VAL VAL SEQRES 2 B 258 ALA ASP HIS ARG PHE TYR ARG TYR MET GLY ARG GLY GLU SEQRES 3 B 258 GLU SER THR THR THR ASN TYR LEU ILE GLU LEU ILE ASP SEQRES 4 B 258 ARG VAL ASP ASP ILE TYR ARG ASN THR ALA TRP ASP ASN SEQRES 5 B 258 ALA GLY PHE LYS GLY TYR GLY ILE GLN ILE GLU GLN ILE SEQRES 6 B 258 ARG ILE LEU LYS SER PRO GLN GLU VAL LYS PRO GLY GLU SEQRES 7 B 258 LYS HIS TYR ASN MET ALA LYS SER TYR PRO ASN GLU GLU SEQRES 8 B 258 LYS ASP ALA TRP ASP VAL LYS MET LEU LEU GLU GLN PHE SEQRES 9 B 258 SER PHE ASP ILE ALA GLU GLU ALA SER LYS VAL CYS LEU SEQRES 10 B 258 ALA HIS LEU PHE THR TYR GLN ASP PHE ASP MET GLY THR SEQRES 11 B 258 LEU GLY LEU ALA TYR GLY GLY SER PRO ARG ALA ASN SER SEQRES 12 B 258 HIS GLY GLY VAL CYS PRO LYS ALA TYR TYR SER PRO VAL SEQRES 13 B 258 GLY LYS LYS ASN ILE TYR LEU ASN SER GLY LEU THR SER SEQRES 14 B 258 THR LYS ASN TYR GLY LYS THR ILE LEU THR LYS GLU ALA SEQRES 15 B 258 ASP LEU VAL THR THR HIS GLU LEU GLY HIS ASN PHE GLY SEQRES 16 B 258 ALA GLU HIS ASP PRO ASP GLY LEU ALA GLU CYS ALA PRO SEQRES 17 B 258 ASN GLU ASP GLN GLY GLY LYS TYR VAL MET TYR PRO ILE SEQRES 18 B 258 ALA VAL SER GLY ASP HIS GLU ASN ASN LYS MET PHE SER SEQRES 19 B 258 GLN CYS SER LYS GLN SER ILE TYR LYS THR ILE GLU SER SEQRES 20 B 258 LYS ALA GLN GLU CYS PHE GLN GLU ARG SER ASN HET ZN A 1 1 HET INN A 9 29 HET ZN B 4 1 HET 002 B 2 32 HETNAM ZN ZINC ION HETNAM INN N-{(2R)-2-[2-(HYDROXYAMINO)-2-OXOETHYL]-4- HETNAM 2 INN METHYLPENTANOYL}-3-METHYL-L-VALYL-N-(2-AMINOETHYL)-L- HETNAM 3 INN ALANINAMIDE HETNAM 002 N-[(2R)-2-BENZYL-4-(HYDROXYAMINO)-4-OXOBUTANOYL]-L- HETNAM 2 002 ISOLEUCYL-L-LEUCINE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 INN C19 H37 N5 O5 FORMUL 6 002 C23 H35 N3 O6 FORMUL 7 HOH *103(H2 O) HELIX 1 1 ASP A 232 MET A 239 1 8 HELIX 2 2 GLU A 243 ASN A 264 1 22 HELIX 3 3 ASP A 313 ILE A 325 1 13 HELIX 4 4 ILE A 325 SER A 330 1 6 HELIX 5 5 PHE A 343 THR A 347 5 5 HELIX 6 6 LEU A 395 PHE A 411 1 17 HELIX 7 7 LEU A 420 ALA A 424 5 5 HELIX 8 8 ASN A 426 GLY A 430 5 5 HELIX 9 9 HIS A 444 MET A 449 5 6 HELIX 10 10 SER A 451 PHE A 470 1 20 HELIX 11 11 ASP B 232 MET B 239 1 8 HELIX 12 12 GLU B 243 ASN B 264 1 22 HELIX 13 13 ASP B 313 ILE B 325 1 13 HELIX 14 14 ILE B 325 SER B 330 1 6 HELIX 15 15 PHE B 343 THR B 347 5 5 HELIX 16 16 LEU B 395 PHE B 411 1 17 HELIX 17 17 ASN B 426 GLY B 430 5 5 HELIX 18 18 HIS B 444 MET B 449 5 6 HELIX 19 19 SER B 451 PHE B 470 1 20 SHEET 1 A 5 GLY A 276 ILE A 284 0 SHEET 2 A 5 THR A 224 ALA A 231 1 N LEU A 227 O GLU A 280 SHEET 3 A 5 LEU A 334 THR A 339 1 O PHE A 338 N VAL A 230 SHEET 4 A 5 SER A 382 SER A 386 1 O THR A 385 N THR A 339 SHEET 5 A 5 GLY A 349 ALA A 351 -1 N LEU A 350 O LEU A 384 SHEET 1 B 2 ALA A 368 SER A 371 0 SHEET 2 B 2 LYS A 376 TYR A 379 -1 O LYS A 376 N SER A 371 SHEET 1 C 2 LYS A 388 ASN A 389 0 SHEET 2 C 2 LYS A 392 THR A 393 -1 O LYS A 392 N ASN A 389 SHEET 1 D 5 GLY B 276 ILE B 284 0 SHEET 2 D 5 THR B 224 ALA B 231 1 N ALA B 231 O ARG B 283 SHEET 3 D 5 LEU B 334 THR B 339 1 O PHE B 338 N VAL B 230 SHEET 4 D 5 SER B 382 SER B 386 1 O THR B 385 N LEU B 337 SHEET 5 D 5 GLY B 349 ALA B 351 -1 N LEU B 350 O LEU B 384 SHEET 1 E 2 ALA B 368 SER B 371 0 SHEET 2 E 2 LYS B 376 TYR B 379 -1 O LYS B 376 N SER B 371 SHEET 1 F 2 LYS B 388 ASN B 389 0 SHEET 2 F 2 LYS B 392 THR B 393 -1 O LYS B 392 N ASN B 389 SSBOND 1 CYS A 225 CYS A 333 1555 1555 2.04 SSBOND 2 CYS A 365 CYS A 469 1555 1555 2.02 SSBOND 3 CYS A 423 CYS A 453 1555 1555 2.02 SSBOND 4 CYS B 225 CYS B 333 1555 1555 2.04 SSBOND 5 CYS B 365 CYS B 469 1555 1555 2.04 SSBOND 6 CYS B 423 CYS B 453 1555 1555 2.04 LINK ZN ZN A 1 O INN A 9 1555 1555 2.10 LINK ZN ZN A 1 O4 INN A 9 1555 1555 2.11 LINK ZN ZN A 1 NE2 HIS A 405 1555 1555 2.12 LINK ZN ZN A 1 NE2 HIS A 409 1555 1555 2.13 LINK ZN ZN A 1 NE2 HIS A 415 1555 1555 2.03 LINK O2 002 B 2 ZN ZN B 4 1555 1555 2.03 LINK O3 002 B 2 ZN ZN B 4 1555 1555 1.96 LINK ZN ZN B 4 NE2 HIS B 405 1555 1555 2.09 LINK ZN ZN B 4 NE2 HIS B 409 1555 1555 2.12 LINK ZN ZN B 4 NE2 HIS B 415 1555 1555 2.16 CISPEP 1 TYR A 304 PRO A 305 0 0.31 CISPEP 2 TYR B 304 PRO B 305 0 0.38 CISPEP 3 SER B 355 PRO B 356 0 0.43 SITE 1 AC1 4 INN A 9 HIS A 405 HIS A 409 HIS A 415 SITE 1 AC2 4 002 B 2 HIS B 405 HIS B 409 HIS B 415 SITE 1 AC3 21 ZN A 1 GLU A 327 SER A 330 LYS A 331 SITE 2 AC3 21 MET A 345 GLY A 346 THR A 347 LEU A 348 SITE 3 AC3 21 GLY A 349 ASN A 389 TYR A 390 HIS A 405 SITE 4 AC3 21 GLU A 406 HIS A 409 HIS A 415 TYR A 436 SITE 5 AC3 21 PRO A 437 ILE A 438 ALA A 439 HOH A 480 SITE 6 AC3 21 HOH A 483 SITE 1 AC4 19 ZN B 4 MET B 345 GLY B 346 THR B 347 SITE 2 AC4 19 LEU B 348 GLY B 349 ASN B 389 TYR B 390 SITE 3 AC4 19 GLU B 398 VAL B 402 HIS B 405 GLU B 406 SITE 4 AC4 19 HIS B 409 HIS B 415 PRO B 437 ALA B 439 SITE 5 AC4 19 VAL B 440 HOH B 495 HOH B 528 CRYST1 73.799 76.221 102.092 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013550 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013120 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009795 0.00000